Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-01-03 Sale |
2022-01-05 5:22 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $140.91 | $704,534 | 85,592 (Indirect Direct) |
View |
2021-12-31 Sale |
2022-01-04 5:04 pm |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
3,750 | $144.16 | $540,601 | 76,590 (Indirect Direct) |
View |
2021-12-20 Sale |
2021-12-22 5:03 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $230 | $1,150,000 | 90,592 (Indirect Direct) |
View |
2021-12-15 Sale |
2021-12-16 5:15 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,686 | $174.13 | $293,584 | 19,807 (Direct) |
View |
2021-12-07 Sale |
2021-12-09 5:20 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $170.14 | $1,403,631 | 86,561 (Direct) |
View |
2021-12-01 Sale |
2021-12-03 6:30 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $196.19 | $980,944 | 94,507 (Indirect Direct) |
View |
2021-11-30 Sale |
2021-12-02 4:13 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,942 | $203.2 | $1,817,000 | 94,811 (Direct) |
View |
2021-11-29 Sale |
2021-12-01 5:02 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $228.72 | $1,143,600 | 99,507 (Indirect Direct) |
View |
2021-11-26 Sale |
2021-11-30 5:06 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,121 | $218.07 | $462,530 | 80,883 (Direct) |
View |
2021-11-23 Sale |
2021-11-24 5:21 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $199.5 | $1,645,914 | 103,061 (Direct) |
View |
2021-11-15 Sale |
2021-11-17 5:25 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
9,433 | $169.79 | $1,601,676 | 120,941 (Direct) |
View |
2021-11-09 Sale |
2021-11-12 5:02 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $167.53 | $1,382,160 | 119,561 (Direct) |
View |
2021-11-03 Sale |
2021-11-05 5:02 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $200 | $1,000,000 | 104,507 (Indirect Direct) |
View |
2021-11-02 Sale |
2021-11-04 5:22 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $183.82 | $1,516,552 | 127,811 (Direct) |
View |
2021-11-01 Sale |
2021-11-03 4:49 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $163.08 | $815,422 | 109,507 (Indirect Direct) |
View |
2021-10-29 Sale |
2021-11-02 7:02 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
680 | $148.34 | $100,871 | 4,061 (Direct) |
View |
2021-10-26 Sale |
2021-10-28 5:09 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,395 | $132.75 | $1,379,902 | 216,331 (Direct) |
View |
2021-10-19 Sale |
2021-10-21 5:08 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $165.14 | $1,362,427 | 144,311 (Direct) |
View |
2021-10-15 Sale |
2021-10-19 5:04 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,183 | $170 | $201,110 | 14,874 (Direct) |
View |
2021-10-12 Sale |
2021-10-14 5:16 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $163.18 | $1,346,218 | 152,561 (Direct) |
View |
2021-10-05 Sale |
2021-10-07 5:18 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $174.41 | $1,438,895 | 160,811 (Direct) |
View |
2021-10-04 Sale |
2021-10-05 5:05 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
42,829 | $176.15 | $7,544,195 | 60,378 (Direct) |
View |
2021-10-01 Sale |
2021-10-05 5:04 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
49,000 | $175.1 | $8,580,064 | 103,207 (Direct) |
View |
2021-10-01 Sale |
2021-10-05 5:02 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $174.89 | $874,452 | 114,507 (Indirect Direct) |
View |
2021-09-30 Sale |
2021-10-01 5:58 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
693 | $207.25 | $143,622 | 4,061 (Direct) |
View |
2021-09-27 Sale |
2021-09-29 5:08 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
2,119 | $234.37 | $496,633 | 87,806 (Direct) |
View |
2021-09-28 Sale |
2021-09-29 5:06 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
7,501 | $209.92 | $1,574,637 | 97,546 (Direct) |
View |
2021-09-27 Sale |
2021-09-29 5:04 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
7,501 | $234.61 | $1,759,833 | 105,047 (Direct) |
View |
2021-09-23 Sale |
2021-09-24 5:10 pm |
NOVAVAX INC | NVAX | MOTT DAVID M Director |
24,961 | $252.9 | $6,312,616 | 40,000 (Direct) |
View |
2021-09-20 Sale |
2021-09-22 5:05 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
15,000 | $227.47 | $3,412,013 | 228,222 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-03-10 Option Award |
2022-03-14 7:45 pm |
N/A 2032-03-10 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
47,235 | $0 | 47,235 (Direct) |
View |
2022-03-10 Option Award |
2022-03-14 7:43 pm |
N/A 2032-03-10 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
103,685 | $0 | 103,685 (Direct) |
View |
2022-01-03 Exercise |
2022-01-05 5:22 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 85,592 (Direct) |
View |
2022-01-03 Exercise |
2022-01-05 5:22 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 85,592 (Direct) |
View |
2021-12-31 Exercise |
2022-01-04 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
3,750 | $25.6 | 76,590 (Direct) |
View |
2021-12-31 Exercise |
2022-01-04 5:04 pm |
2012-09-01 2022-03-01 |
NOVAVAX INC | NVAX | YOUNG JAMES F Director |
3,750 | $0 | 76,590 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 5:03 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 90,592 (Direct) |
View |
2021-12-20 Exercise |
2021-12-22 5:03 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 90,592 (Direct) |
View |
2021-12-14 Tax Withholding |
2021-12-16 5:18 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
773 | $168.43 | 6,573 (Direct) |
View |
2021-12-14 Exercise |
2021-12-16 5:18 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
1,600 | $0 | 6,573 (Direct) |
View |
2021-12-14 Tax Withholding |
2021-12-16 5:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
1,015 | $168.43 | 9,792 (Direct) |
View |
2021-12-14 Exercise |
2021-12-16 5:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,100 | $0 | 9,792 (Direct) |
View |
2021-12-15 Exercise |
2021-12-16 5:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,024 | $27.6 | 19,807 (Direct) |
View |
2021-12-15 Exercise |
2021-12-16 5:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
662 | $46 | 19,807 (Direct) |
View |
2021-12-14 Tax Withholding |
2021-12-16 5:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,498 | $168.43 | 19,807 (Direct) |
View |
2021-12-14 Exercise |
2021-12-16 5:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
4,786 | $0 | 19,807 (Direct) |
View |
2021-12-14 Tax Withholding |
2021-12-16 5:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
3,366 | $168.43 | 41,413 (Direct) |
View |
2021-12-14 Exercise |
2021-12-16 5:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
6,967 | $0 | 41,413 (Direct) |
View |
2021-12-13 Exercise |
2021-12-15 5:22 pm |
N/A N/A |
NOVAVAX INC | NVAX | DOUGLAS RICHARD Director |
1,500 | $25.6 | 33,450 (Direct) |
View |
2021-12-13 Exercise |
2021-12-15 5:22 pm |
2012-09-01 2022-03-01 |
NOVAVAX INC | NVAX | DOUGLAS RICHARD Director |
1,500 | $0 | 33,450 (Direct) |
View |
2021-12-07 Exercise |
2021-12-09 5:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 86,561 (Direct) |
View |
2021-12-07 Exercise |
2021-12-09 5:20 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 86,561 (Direct) |
View |
2021-12-01 Exercise |
2021-12-03 6:30 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 94,507 (Direct) |
View |
2021-12-01 Exercise |
2021-12-03 6:30 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 94,507 (Direct) |
View |
2021-11-30 Exercise |
2021-12-02 4:13 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 94,811 (Direct) |
View |
2021-11-30 Exercise |
2021-12-02 4:13 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 94,811 (Direct) |
View |
2021-11-29 Exercise |
2021-12-01 5:02 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 99,507 (Direct) |
View |
2021-11-29 Exercise |
2021-12-01 5:02 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 99,507 (Direct) |
View |
2021-11-26 Exercise |
2021-11-30 5:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,460 | $5.95 | 80,883 (Direct) |
View |
2021-11-26 Tax Withholding |
2021-11-30 5:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
647 | $217.97 | 80,883 (Direct) |
View |
2021-11-26 Exercise |
2021-11-30 5:06 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,460 | $0 | 80,883 (Direct) |
View |
2021-11-23 Exercise |
2021-11-24 5:21 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 103,061 (Direct) |
View |
2021-11-23 Exercise |
2021-11-24 5:21 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 103,061 (Direct) |
View |
2021-11-15 Exercise |
2021-11-17 5:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
521 | $27.6 | 120,941 (Direct) |
View |
2021-11-15 Exercise |
2021-11-17 5:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
662 | $46 | 120,941 (Direct) |
View |
2021-11-16 Exercise |
2021-11-17 5:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 120,941 (Direct) |
View |
2021-11-15 Exercise |
2021-11-17 5:25 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
9,433 | $0 | 120,941 (Direct) |
View |
2021-11-09 Exercise |
2021-11-12 5:02 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 119,561 (Direct) |
View |
2021-11-09 Exercise |
2021-11-12 5:02 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 119,561 (Direct) |
View |
2021-11-03 Exercise |
2021-11-05 5:02 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 104,507 (Direct) |
View |
2021-11-03 Exercise |
2021-11-05 5:02 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 104,507 (Direct) |
View |
2021-11-02 Exercise |
2021-11-04 5:22 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 127,811 (Direct) |
View |
2021-11-02 Exercise |
2021-11-04 5:22 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 127,811 (Direct) |
View |
2021-11-01 Exercise |
2021-11-03 4:49 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 109,507 (Direct) |
View |
2021-11-01 Exercise |
2021-11-03 4:49 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 109,507 (Direct) |
View |
2021-10-26 Exercise |
2021-10-28 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,462 | $5.95 | 216,331 (Direct) |
View |
2021-10-26 Tax Withholding |
2021-10-28 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
637 | $134.99 | 216,331 (Direct) |
View |
2021-10-26 Exercise |
2021-10-28 5:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 216,331 (Direct) |
View |
2021-10-26 Exercise |
2021-10-28 5:09 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
11,712 | $0 | 216,331 (Direct) |
View |
2021-10-19 Exercise |
2021-10-21 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 144,311 (Direct) |
View |
2021-10-19 Exercise |
2021-10-21 5:08 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 144,311 (Direct) |
View |
2021-10-15 Exercise |
2021-10-19 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
521 | $27.6 | 14,874 (Direct) |
View |
2021-10-15 Exercise |
2021-10-19 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
662 | $46 | 14,874 (Direct) |
View |
2021-10-15 Exercise |
2021-10-19 5:04 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,183 | $0 | 14,874 (Direct) |
View |
2021-10-12 Exercise |
2021-10-14 5:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 152,561 (Direct) |
View |
2021-10-12 Exercise |
2021-10-14 5:16 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 152,561 (Direct) |
View |
2021-10-05 Exercise |
2021-10-07 5:18 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $19.08 | 160,811 (Direct) |
View |
2021-10-05 Exercise |
2021-10-07 5:18 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
8,250 | $0 | 160,811 (Direct) |
View |
2021-10-04 Exercise |
2021-10-05 5:05 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
32,000 | $27.6 | 60,378 (Direct) |
View |
2021-10-04 Exercise |
2021-10-05 5:05 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
10,829 | $27 | 60,378 (Direct) |
View |
2021-10-04 Exercise |
2021-10-05 5:05 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
42,829 | $0 | 60,378 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
14,000 | $27.6 | 103,207 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
35,000 | $27 | 103,207 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 5:04 pm |
N/A 2027-12-15 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
49,000 | $0 | 103,207 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 5:02 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $19.08 | 114,507 (Direct) |
View |
2021-10-01 Exercise |
2021-10-05 5:02 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
5,000 | $0 | 114,507 (Direct) |
View |
2021-09-27 Tax Withholding |
2021-09-29 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
648 | $231.04 | 87,806 (Direct) |
View |
2021-09-27 Exercise |
2021-09-29 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,460 | $5.95 | 87,806 (Direct) |
View |
2021-09-27 Exercise |
2021-09-29 5:08 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,460 | $0 | 87,806 (Direct) |
View |
2021-09-28 Exercise |
2021-09-29 5:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
7,501 | $19.08 | 97,546 (Direct) |
View |
2021-09-28 Exercise |
2021-09-29 5:06 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
7,501 | $0 | 97,546 (Direct) |
View |
2021-09-27 Exercise |
2021-09-29 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
7,501 | $19.08 | 105,047 (Direct) |
View |
2021-09-27 Exercise |
2021-09-29 5:04 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
7,501 | $0 | 105,047 (Direct) |
View |
2021-09-26 Tax Withholding |
2021-09-28 5:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
1,709 | $248.16 | 6,084 (Direct) |
View |
2021-09-26 Exercise |
2021-09-28 5:06 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
3,537 | $0 | 6,084 (Direct) |
View |
2021-09-26 Tax Withholding |
2021-09-28 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,141 | $248.16 | 9,147 (Direct) |
View |
2021-09-26 Exercise |
2021-09-28 5:04 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
4,639 | $0 | 9,147 (Direct) |
View |
2021-09-26 Tax Withholding |
2021-09-28 5:02 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
3,162 | $248.16 | 30,425 (Direct) |
View |
2021-09-26 Exercise |
2021-09-28 5:02 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
6,546 | $0 | 30,425 (Direct) |
View |
2021-08-24 Tax Withholding |
2021-09-24 5:08 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
697 | $233.01 | 4,009 (Indirect) |
View |
2021-08-24 Exercise |
2021-09-24 5:08 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,000 | $0 | 4,009 (Indirect) |
View |
2021-09-20 Exercise |
2021-09-22 5:05 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
15,000 | $19.08 | 228,222 (Direct) |
View |
2021-09-20 Exercise |
2021-09-22 5:05 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Trizzino John EVP, CCO and CBO |
15,000 | $0 | 228,222 (Direct) |
View |